Liquid Biopsy: Catching Cancer Early With a Simple Blood Test

In 2010, scientists Catherine Alix-Panabières and Klaus Pantel coined the term “liquid biopsy”, which Nature later named one of the key cancer discoveries of the last 20 years. Their blood-based approach can detect cancer early, spare patients painful needle biopsies, help doctors choose the right …

Why Youth Are Taking to the Streets: From Paris to Belgrade to India

 In this Morning Brief conversation, Dia Rekhi speaks with political scientist and and researcher at CERI, Sciences Po Paris Gilles Verniers about the wave of youth-led protests sweeping the globe. Starting with France’s student-led movement, they explore why young people anchor these uprisings, wh…

OpenAI's India Bet: From ChatGPT Users to AI-Powered Businesses

India has become ChatGPT’s largest market by weekly active users. But can OpenAI turn that extraordinary reach into a sustainable business? In this conversation with The Economic Times’ tech editor Surabhi Agarwal, OpenAI India Managing Director Prabhjeet Singh discusses the shift from AI experimen…

India's Banks Under Cyberattack: How AI Is Changing the Game

India's rapidly expanding financial ecosystem faces a growing cybersecurity challenge. While large banks have invested heavily in protecting their systems, fintech companies and non-banking financial institutions remain vulnerable to increasingly sophisticated attacks. Artificial intelligence is ch…

The Cancer Drug Price Trap

Why does a cancer injection bought by a hospital for ₹11,000 end up costing a patient ₹1.3 lakh? India’s drug pricing system is under scrutiny as the government caps trade margins on hundreds of cancer medicines at 30%. While prices of several drugs have fallen sharply, nearly one in four packs has…

AI Agents Are Breaking the Internet’s Ad Model

When AI agents book your flights, buy your groceries and pick your hotels, no one is scrolling, and no one sees an ad. So how does the internet make money? Lightspeed India partners Harsha Kumar and Hemanth Mohapatra explain which purchases agents will take over and which will stay human. They als…

China vs US: The New War Over Cancer Drugs and Biotech Supremacy | The Morning Brief Decode

China challenged America's dominance in manufacturing, technology and artificial intelligence. Now, it is threatening another American stronghold: the pharmaceutical industry. Chinese biotech companies are developing breakthrough drugs faster and cheaper than their American counterparts. One Chine…

Does Slumping Smartphone Demand Spell a Gloomy Diwali?

India’s smartphone market is heading into Diwali on a sour note. Shipments fell sharply in the July–September quarter, with the sub-₹20,000 segment hit hardest. A global memory-chip crunch is raising costs, pushing up prices and forcing buyers to delay upgrades, settle for fewer features or choose …

The $1.5 Billion Bet on a World Without Coders | Emergent’s Mukund Jha

What if you didn’t need a tech team, or any code, to build software? In this episode of Corner Office Conversation, Anirban Chowdhury sits down with Mukund Jha, Founder and CEO of Emergent, the AI platform where anyone with an idea can build a real, hosted, working app. A former Google engineer, Mu…

Yes Bank AT1 Bonds: Why the Supreme Court Reversed the ₹8,415 Crore Write-Down

The Supreme Court has set aside Yes Bank’s 2020 write-down of ₹8,415 crore in AT1 bonds. Anirban Chowdhury speaks to Sugata Ghosh of The Economic Times about how AT1 bonds work, why the Court ruled against the write-down, what the judgment means for investors and regulators, and how the case compar…